Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
3.
Allergol. immunopatol ; 44(5): 393-399, sept.-oct. 2016. tab, graf
Artículo en Inglés | IBECS (España) | ID: ibc-155849

RESUMEN

OBJECTIVES: Wheezing is a very common problem in infants in the first months of life. The objective of this study is to identify risk factors that may be acted upon in order to modify the evolution of recurrent wheezing in the first months of life, and to develop a model based on certain factors associated to recurrent wheezing in nursing infants capable of predicting the probability of developing recurrent wheezing in the first year of life. METHODS: The sample was drawn from a cross-sectional, multicentre, descriptive epidemiological study based on the general population. A total of 1164 children were studied, corresponding to a questionnaire response rate of 71%. The questionnaire of the Estudio Internacional de Sibilancias en Lactantes (EISL) was used. Multiple logistic regression analysis was used to estimate the probability of developing recurrent wheezing and to quantify the contribution of each individual variable in the presence of the rest. RESULTS: Infants presenting eczema and attending nursery school, with a mother who has asthma, smoked during the third trimester of pregnancy, and did not consume a Mediterranean diet during pregnancy were found to have a probability of 79.7% of developing recurrent wheezing in the first year of life. In contrast, infants with none of these factors were seen to have a probability of only 4.1% of developing recurrent wheezing in the first year of life. These results in turn varied according to modifications in the risk or protective factors. CONCLUSIONS: The mathematical model estimated the probability of developing recurrent wheezing in infants under one year of age in the province of Salamanca (Spain), according to the risk or protective factors associated to recurrent wheezing to which the infants are or have been exposed


No disponible


Asunto(s)
Humanos , Masculino , Femenino , Lactante , Modelos Teóricos/métodos , Modelos Teóricos/políticas , Ruidos Respiratorios/diagnóstico , Ruidos Respiratorios/inmunología , Factores de Riesgo , Asma/complicaciones , Asma/diagnóstico , Modelos Teóricos/estadística & datos numéricos , Encuestas y Cuestionarios
4.
Allergol. immunopatol ; 43(6): 543-552, nov-dic. 2015. tab, graf
Artículo en Inglés | IBECS (España) | ID: ibc-145499

RESUMEN

OBJECTIVES: To determine the prevalence of wheezing during the first year of life in Cantabria, Spain and its associated risk factors. METHODOLOGY: A cross-sectional, multicentre, descriptive epidemiological study was carried out in a representative sample of 958 infants in the first year of life, born in Cantabria. A previously validated and standardised written questionnaire was completed by the parents of infants seen between 12 and 15 months of age in the Primary Care Centres. RESULTS: The prevalence of wheezing was 32.7%. A relationship was found with male gender (OR 1.38, 95%CI [1.05-1.81]), the presence of a sibling (OR 2.43 [1.38-3.98]), attending nursery school (OR 2.40 [1.71-3.35]), exclusive breastfeeding for <3 months (OR 1.47 [1.12-1.93]), a first cold at ≤3 months (OR 2.07 [1.56-2.74]), asthma in siblings (OR 2.17 [1.25-3.77]), parental allergic rhinitis (OR 1.62 [1.10-2.37]) and paracetamol use >1 a week (OR 2.49 [1.31-4.73]), and maternal smoking during pregnancy (OR 2.18 [1.51-3.15]). The prevalence of recurrent wheezing (≥3 episodes) was 14.3%. Significant associations were observed with the male gender (OR 1.79 [1.23-2.60]), attending nursery school (OR 2.92 [1.96-4.35]), first cold at ≤3 months (OR 2.11 [1.46-3.04]), eczema (OR 1.92 [1.21-3.04]), maternal asthma (OR 1.77 [1.00-3.14]), exclusive breastfeeding for <3 months (OR 1.53 [1.06-2.22]), and maternal smoking during pregnancy (OR 1.53 [1.05-2.22]). CONCLUSIONS: One third of the infants experienced wheezing during the first year of life; those who were less exclusively breastfed, attended nursery school, presented eczema, family asthma or allergic rhinitis, and maternal smoking during pregnancy


No disponible


Asunto(s)
Humanos , Masculino , Femenino , Lactante , Embarazo , Recién Nacido , Factores Sexuales , Ruidos Respiratorios/etiología , Asma/epidemiología , Factores de Riesgo , Asma/complicaciones , Estudios Transversales , Exposición a Riesgos Ambientales/efectos adversos , España , Prevalencia , Facultades de Enfermería , Lactancia Materna , Fumar/efectos adversos
5.
Allergol. immunopatol ; 43(6): 601-608, nov-dic. 2015. tab
Artículo en Inglés | IBECS (España) | ID: ibc-145507

RESUMEN

Asthma is a complex disease determined by the interaction of different genes and environmental factors. The first genetic investigations in asthma were candidate gene association studies and linkage studies. In recent years research has focused on association studies that scan the entire genome without any prior conditioning hypothesis: the so-called genome-wide association studies (GWAS). The first GWAS was published in 2007, and described a new locus associated to asthma in chromosome 17q12-q21, involving the ORMDL3, GSDMB and ZPBP2 genes (a description of the genes named in the manuscript are listed in Table 1). None of these genes would have been selected in a classical genetic association study since it was not known they could be implicated in asthma. To date, a number of GWAS studies in asthma have been made, with the identification of about 1000 candidate genes. Coordination of the different research groups in international consortiums and the application of new technologies such as new generation sequencing will help discover new implicated genes and improve our understanding of the molecular mechanisms underlying the disease


No disponible


Asunto(s)
Humanos , Animales , Genómica , Asma/genética , Cromosomas Humanos Par 17/genética , Proteínas de Neoplasias/genética , Proteínas de la Membrana/genética , Asma/diagnóstico , Mutación/genética , Secuenciación de Nucleótidos de Alto Rendimiento , Epigénesis Genética , Predisposición Genética a la Enfermedad , Proteínas del Huevo/genética , Biomarcadores/metabolismo
6.
Allergol. immunopatol ; 42(6): 603-608, nov.-dic. 2014. tab
Artículo en Inglés | IBECS (España) | ID: ibc-130152

RESUMEN

Asthma is a complex disease involving numerous mediator molecules and effector cells, in combination with a range of environmental determining factors. Cytokines play a key role in the physiopathological mechanisms of asthma; the study of the structure, regulation and variations of the genes that encode for these molecules is therefore crucial. Cytokines have extremely diverse roles, and exert effects both as activators and inhibitors of the innate and adaptive immune response. Certain modifications in the expression or structure of these molecules, resulting from the presence of polymorphisms, may give rise to deregulation of the mentioned effects, and therefore to a predisposition to develop concrete asthma phenotypes


No disponible


Asunto(s)
Humanos , Citocinas/análisis , Asma/fisiopatología , Hipersensibilidad Respiratoria/fisiopatología , Inflamación/fisiopatología , Interleucinas/análisis , Factores de Crecimiento Transformadores/análisis , Linfotoxina-alfa/análisis
7.
Allergol. immunopatol ; 42(1): 64-68, ene.-feb. 2014. ilus
Artículo en Inglés | IBECS (España) | ID: ibc-119055

RESUMEN

The prostaglandin D2 receptor (PTGDR) gene has been associated to asthma and related phenotypes by linking and association studies. Functional studies involving animal models and other expression studies based on in vitro cell models also point to a possible role of polymorphisms in the promoter region, in the differential binding of transcription factors, and thus in PTGDR expression, which appear to be associated to the development of asthma or of susceptibility to the disease


No disponible


Asunto(s)
Humanos , Asma/inmunología , Hipersensibilidad/inmunología , Receptores de Tromboxano A2 y Prostaglandina H2/inmunología , Prostaglandina D2/inmunología , Hipersensibilidad Inmediata/inmunología
8.
Allergol. immunopatol ; 40(3): 164-171, mayo-jun. 2012. tab, graf
Artículo en Inglés | IBECS (España) | ID: ibc-99345

RESUMEN

Objectives: To determine the prevalence of wheezing and its associated risk factors in infants in the first year of life in the province of Salamanca, Spain. Methods: A multicentre, cross-sectional, descriptive epidemiological study was designed to evaluate a representative sample of 750 infants in the first year of life, born in the province of Salamanca between 1 June 2008 and 30 September 2009.The study was based on a previously validated and standardised written questionnaire administered among the parents of those children seen for control at 12 months of age in any of the Primary Care centres in the province of Salamanca. Results: The recorded wheezing rate was 32.3%. Feeding and sleep were seen to be affected in 46.3% and 80.9% of the wheezing children, respectively, and parent activity was also altered in 39.3% of the cases. A relationship was found between wheezing and nursery attendance (OR: 1.66, 95% confidence interval [1.19-2.31]); weight at birth >3500g (OR: 1.45 [1.02-2.06]); the presence of eczema at this age (OR: 2.72 [1.75-4.24]); exclusive breastfeeding for <3 months (OR: 1.33 [0.98-1.81]); and maternal smoking during the last three months of pregnancy (OR: 1.60 [0.96-2.68]).The prevalence of recurrent wheezing (defined as three or more episodes) was 11.9%. Significant differences were observed with respect to nursery attendance (OR: 1.71 [1.08-2.72]), the presence of eczema at this age (OR: 2.55 [1.48-4.42]), a history of maternal asthma (OR: 2.19 [1.08-4.44]) and exclusive breastfeeding for <3 months (OR: 1.53 [0.98-2.38]). Conclusions: In the province of Salamanca, one third of the infants studied suffered wheezing in the first year of life. Infants exclusively breastfed for less than three months; attending a nursery; having suffered eczema; or with an asthmatic mother showed significantly more wheezing than the rest. Wheezing proved recurrent in 11.9% of the cases(AU)


Asunto(s)
Humanos , Masculino , Femenino , Lactante , Ruidos Respiratorios/diagnóstico , Asma/epidemiología , Factores de Riesgo , Enfermedades Respiratorias/epidemiología , Eccema/epidemiología
9.
Allergol. immunopatol ; 38(6): 307-312, nov.-dic. 2010. tab, graf
Artículo en Inglés | IBECS (España) | ID: ibc-83249

RESUMEN

Background: The determination of pollen types and their proportions in the atmosphere of relevant urban areas have increasingly been evaluated in different regions. The final goal has been to elaborate a pollen calendar, providing data about the occurrence of pollen grains in the air, thus permitting medical treatment and prophylaxis. Methods: An aerobiological study was carried out in the atmosphere of the city of Salamanca, Spain, during eight years (2000–2007) by means of a Hirst type volumetric spore trap. A pollen calendar was elaborated following exponential classes obtained from 10-day average concentrations of the main pollen types. Results: Mean annual pollen index was 16,916, coming from 72 different types of pollen. During the studied period, an increase of annual pollen levels was registered by means of regression analysis index. The most important types of pollen were Quercus, Poaceae, Cupressaceae, Olea, and Plantago. Arboreal pollen grains (62.7%) were more represented in airborne pollen spectrum than non-arboreal pollen (37.3%). Airborne pollen levels were particularly high between April and July, showing the highest values in May and June. Conclusions: In aerobiological terms Poaceae pollen seems to be a major risk for potential sensitised individuals due to its known allergenicity and its high atmospheric concentrations between late spring and early summer, followed by Cupressaceae, Olea and Platanus pollen grains, and taking into account the possible role of Fraxinus and Quercus in earl spring allergenic courses and in processes of cross-sensitivity, respectively


Asunto(s)
Rinitis Alérgica Estacional/prevención & control , Asma/prevención & control , Contaminantes Atmosféricos/análisis , Estaciones del Año/métodos , Polen
11.
Allergol. immunopatol ; 35(6): 254-258, nov. 2007.
Artículo en En | IBECS (España) | ID: ibc-058250

RESUMEN

Epigenetics is defined as those inheritable changes occurring in gene expression, without actual modification in the genic DNA sequence. Epigenetic factors are chemically stable, potentially reversible, and can be modulated or induced by environmental factors. In the case of allergic disease, epigenetics could explain not only the discordances observed between monozygous twins but also phenomena such as incomplete penetrance, variable expression, gender and progenitor effects, and sporadic cases. In this sense, the hypothesis of hygiene is of great relevance in that it integrates genetic and epidemiological data in the context of environmental exposures. Among the different epigenetic factors, mention must be made of DNA methylation, covalent histone modifications, and other mechanisms that include different protein complexes and RNA-mediated modifications. The regulatory effect of these phenomena upon immune response has important implications for allergic diseases. At present, different lines of pharmacological research are being conducted, based on the modulation of epigenetic factors, modifying expression of the genes that encode for proteins implicated in allergic processes. Among such modulators, mention can be made of antisense oligonucleotides, ribozymes and interference RNA. The applications of epigenetics to the diagnosis and treatment of allergic disorders offer a very promising future of this specialty


La Epigenética se define como aquellos cambios heredables que se producen en la expresión génica sin modificar la secuencia de DNA. Los factores epigenéticos se caracterizan por ser químicamente estables, potencialmente reversibles y modulables o inducibles por factores ambientales. En el caso de las enfermedades alérgicas la epigenética podría contribuir a explicar no sólo las discordancias observadas en los gemelos monocigóticos, sino también fenómenos como la penetrancia incompleta, la expresión variable, los efectos del sexo y del progenitor de origen y los casos esporádicos. En este sentido, la hipótesis de la higiene cobra gran relevancia al integrar datos genéticos y epidemiológicos en el marco de las exposiciones ambientales. Entre los factores epigenéticos destacan la metilación del DNA, las modificaciones covalentes de las histonas y otros mecanismos que incluyen distintos complejos proteicos y las modificaciones mediadas por RNA. El efecto regulador de estos fenómenos sobre la respuesta inmune tiene grandes implicaciones en las enfermedades alérgicas. En la actualidad se están desarrollando distintas líneas de investigación farmacológica basadas en la modulación de los factores epigenéticos, modificando la expresión de los genes que codifican proteínas implicadas en los procesos alérgicos. Entre estos moduladores destacan los oligonucleótidos antisentido, las ribozimas y los RNA de interferencia. Las aplicaciones de la epigenética al diagnóstico y tratamiento de las enfermedades alérgicas abre un campo muy esperanzador en el futuro de esta especialidad


Asunto(s)
Masculino , Femenino , Humanos , Ambiente , Genes , Genes/fisiología , Metilación de ADN , Genes/inmunología , Alergia e Inmunología/educación , Alergia e Inmunología/organización & administración , Alergia e Inmunología/tendencias , Hipersensibilidad/epidemiología , Hipersensibilidad/inmunología , Células Germinativas/inmunología
12.
Allergol. immunopatol ; 35(supl.1): 26-30, mayo 2007.
Artículo en Español | IBECS (España) | ID: ibc-144837

RESUMEN

La epigenética se define como aquellos cambios heredables que se producen en la expresión génica sin modificar la secuencia de DNA. Los factores epigenéticos se caracterizan por ser químicamente estables, potencialmente reversibles y modulables o inducibles por factores ambientales. En el caso de las enfermedades alérgicas la epigenética podría contribuir a explicar, no sólo las discordancias observadas en los gemelos monocigóticos sino también fenómenos como la penetrancia incompleta, la expresión variable, los efectos del sexo y del progenitor de origen y los casos esporádicos. En este sentido, la hipótesis de la higiene cobra gran relevancia al integrar datos genéticos y epidemiológicos en el marco de las exposiciones ambientales. Entre los factores epigenéticos destacan la metilación del DNA, las modificaciones covalentes de las histonas y otros mecanismos que incluyen distintos complejos proteicos y las modificaciones mediadas por RNA. El efecto regulador de estos fenómenos sobre la respuesta inmune tiene grandes implicaciones en las enfermedades alérgicas. En la actualidad se están desarrollando distintas líneas de investigación farmacológica basadas en la modulación de los factores epigenéticos, modificando la expresión de los genes que codifican proteínas implicadas en los procesos alérgicos. Entre estos moduladores destacan los oligonucleótidos antisentido, las ribozimas y los RNA de interferencia. Las aplicaciones de la epigenética al diagnóstico y tratamiento de las enfermedades alérgicas abre un campo muy esperanzador en el futuro de esta especialidad (AU)


No disponible


Asunto(s)
Humanos , Epigénesis Genética , Silenciador del Gen , Hipersensibilidad/fisiopatología , Metilación de ADN , Histonas/análisis , Balance Th1 - Th2 , Ambiente
13.
Alergol. inmunol. clín. (Ed. impr.) ; 20(6): 238-245, dic. 2005.
Artículo en Es | IBECS (España) | ID: ibc-055359

RESUMEN

La biotecnología consiste en la aplicación de técnicas de biología molecular y/o DNA recombinante, o la transferencia in vitro de genes (bioingeniería), para el desarrollo de nuevos productos o para dotar de nuevas características a organismos ya existentes. A pesar de los beneficios potenciales que entrañan esos métodos, han surgido elementos de preocupación tanto en lo que respecta a su repercusión para la salud como para el medio ambiente. Desde un punto de vista alergológico, esos riesgos potenciales incluyen tanto la adicción de alérgenos conocidos a alimentos previamente no alergénicos, como la formación de nuevos alérgenos y la consiguiente posibilidad de sensibilización en la población expuesta susceptible. En el conocido como Protocolo de Cartagena sobre Bioseguridad se establecieron los criterios de evaluación de los riesgos que suponen los organismos modificados genéticamente. Por otra parte, la Organización de las Naciones Unidas para la Alimentación y la Agricultura (FAO), de forma conjunta con la Organización Mundial de la Salud (OMS), han advertido también desde un punto de vista científico sobre la necesidad de evaluar la seguridad de los alimentos derivados de animales o plantas modificados genéticamente. En la presente revisión hemos querido hacer un repaso de los métodos utilizados para evaluar los potenciales riesgos de alergenicidad de los alimentos modificados genéticamente, así como de la actual legislación europea a este respecto


Biotecnology is the application of the techniques of molecular biology and/or recombinant DNA technology, or in vitro gene transfer (bioengineering), to develop products or impart specific capabilities to organisms. Despite potential benefits of such techniques, concerns have been raised about the potential consequences on health or environment. From an allergic stanpoint, potential risks include the transfer of a known allergen from a crop into a non- allergenic crop, and the creation of neo-allergens that leads the appearance of the novo sensitizaions in the allergic population. In the Cartagena Protocol on Biosafety standards for risks assessment of genetically modified organisms have been set. On the other hand, the Food and Agriculture Organization of the United Nations (FAO) joined to the World Health Organization (WHO) have provided scientific advice on the safety assessment of foods derived from genetically modified animals or plants. This review presents an overview of the methods used for the assessment of the potential allergenic risk of genetically modified foods and the current European legislation on this issue


Asunto(s)
Humanos , Plantas Modificadas Genéticamente/efectos adversos , Plantas Modificadas Genéticamente/inmunología , Alimentos Modificados Genéticamente , Hipersensibilidad a los Alimentos/etiología , Legislación Alimentaria , Ingeniería Genética , Alérgenos/efectos adversos , Alérgenos/genética , Seguridad de Productos para el Consumidor , España
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA